Treatment compliance with lercanidipine. electra study
نویسندگان
چکیده
منابع مشابه
Antihypertensive effectiveness of lercanidipine administered using an electronic pillbox compared with usual care in a cohort of mild-to-moderately hypertensive patients: the ELECTRA study
Vivencio Barrios1†, Carlos Escobar1, Ángel Navarro2, Alberto Calderón1 & Luis M Ruilope3; on behalf of the ELECTRA Investigators †Author for correspondence 1Department of Cardiology, Hospital Ramón y Cajal, Ctra. Colmenar km 9.100, 28034 Madrid, Spain Tel.: +34 913 368 259; Fax: +34 913 368 665; E-mail: vbarriosa@ meditex.es; vbarrios.hrc@ salud.madrid.org 2Medical Department, Recordati Spain, ...
متن کاملLercanidipine in patients with chronic renal failure: the ZAFRA study.
OBJECTIVE The objective was primary to evaluate the safe use of a new calcium channel blocker, lercanidipine, in patients with chronic renal failure (CRF). The secondary objective was to study the protective effect of calcium channel blocker on renal function in CRF patients previously treated with ACE inhibitors or angiotensin receptor blockers. DESIGN AND METHODS The study recruited 203 CRF...
متن کاملCompliance with maintenance treatment of asthma (ADERE study).
OBJECTIVE To determine the rate of compliance with preventive treatment of moderate and severe persistent asthma. METHODS Physicians at various medical centers across the country were invited to nominate patients for participation in the study. Inclusion criteria were being over the age of 12 and presenting moderate or severe persistent asthma. Participating patients received salmeterol/fluti...
متن کاملPulsed Power for the Electra
Electra is a rep-rate Krypton Fluoride (KrF) laser that will be used to develop the technology required for an Inertial Fusion Energy (IFE) Power Plant. Electra will use the same type of architecture as the Nike 60 em amplifier [1], e.g. double-sided electron beam pumping of the laser gas, but it will run at 5 Hz and use technologies that can meet the IFE requirements for efficiency, durability...
متن کاملCalcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension.
Essential hypertension is associated with impaired endothelium-dependent vasodilation caused by oxidative stress-induced nitric oxide (NO) breakdown and compensatory production of a hyperpolarizing factor. To test whether calcium antagonist treatment can restore NO availability and prevent hyperpolarization through antioxidant properties, in 15 healthy subjects and 15 patients with essential hy...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Hypertension
سال: 2002
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(02)02397-x